BGE-102, a Novel NLRP3 Inhibitor, Demonstrated Robust Anti-Inflammatory Activity in an Ongoing Phase 1 Study in Healthy Volunteers and Participants with Obesity

BGE-102 - BioAge Labs

https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ADA26&id=259

PAUL RUBIN; LINGLING CHEN; ADITI DESHPANDE; TAIZ SALAZAR; CHRISTOPHER PATIL; ANN NEALE; ERIC MORGEN; PATRICK MARTIN; KEVIN WILHELMSEN; KRISTEN FORTNEY

Mar 25, 2026